kynurenic acid has been researched along with Neurogenic Inflammation in 1 studies
Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.
Neurogenic Inflammation: Inflammation caused by an injurious stimulus of peripheral neurons and resulting in release of neuropeptides which affect vascular permeability and help initiate proinflammatory and immune reactions at the site of injury.
Excerpt | Relevance | Reference |
---|---|---|
" Neurogenic inflammation is presumed to be an important factor in migraine pathophysiology, mediated by the activation of primary neurons, leading to the release of various pro-inflammatory neuropeptides and neurotransmitters such as Calcitonin Gene-Related Peptide (CGRP), substance P (SP), and vasoactive intestinal peptide (VIP)." | 4.95 | Migraine, Neurogenic Inflammation, Drug Development - Pharmacochemical Aspects. ( Edvinsson, L; Fulop, F; Lukacs, M; Tajti, J; Toldi, J; Vecsei, L, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lukacs, M | 1 |
Tajti, J | 1 |
Fulop, F | 1 |
Toldi, J | 1 |
Edvinsson, L | 1 |
Vecsei, L | 1 |
1 review available for kynurenic acid and Neurogenic Inflammation
Article | Year |
---|---|
Migraine, Neurogenic Inflammation, Drug Development - Pharmacochemical Aspects.
Topics: Animals; Calcitonin Gene-Related Peptide; Drug Discovery; Humans; Kynurenic Acid; Migraine Disorders | 2017 |